Purchase Order HHSD2002016M91749P
Award Date
9/21/16
Potential Completion Date
3/20/17
Potential Value
$150K
Federal Agency
CDC Pittsburgh
Awardee
Qoolabs Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a small disadvantaged business located in Carlsbad, California. The contract is for research and development under the Small Business Innovation Research (SBIR) program, with a period of performance through September 2025. Qoolabs is developing medical technologies related to infectious diseases, immunology,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis epilepsy. The $150,000 firm-fixed-price contract was awarded on September 17, 2018 with a completion date of September 16, 2019. Qoolabs Inc. has received over $4 million in prime federal...
This is a small business set-aside contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a woman-owned small disadvantaged business in California. The $300,000 firm-fixed-price contract is for the development of affinity reagents for the immune system of guinea pigs. Qoolabs Inc. has previously received over $4 million in prime federal contracts from HHS agencies like NIAID and NCI for research and...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc., a self-certified small disadvantaged business, for the development of affinity reagents for the immune system of guinea pigs. The $300,000 firm-fixed-price contract was awarded under the SBIR program and has a completion date of June 30, 2021. Qoolabs Inc. is a corporate entity that has received over $4 million in prime...
This is a $1,500,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Qoolabs Inc., a woman-owned small disadvantaged business located in Carlsbad, California. The contract is for the production of affinity reagents for the immune system of guinea pigs, including interleukins IL1B, IL2, IL4, IL6, IL8, IL10, IL12, and IL13. There was no set-aside used for this award. Qoolabs Inc. has extensive...
This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract for $299,991.00 to Qoolabs Inc., a self-certified small disadvantaged business. The contract is for the development of point-of-care diagnostics for the detection of the liver flukes Opisthorchis viverrini and Clonorchis sinensis, under Topic 388. The work will be performed by Qoolabs Inc. in San Diego, California. Qoolabs Inc....
This $300,000 firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for the development of point-of-care hepatitis C virus core antigen detection and was awarded under the Small Business Innovation Research program's solicitation PHS-2021-1. This total small business set-aside opportunity sought proposals for innovative...
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...